ライフサイエンスコーパス: long-term survival rate

1 tein expression was associated with a better long-term survival rate.

2 e surgical mortality rate but did affect the long-term survival rate.

3 Endpoints were short- and long-term survival rates.

4 oradiotherapy has also been shown to improve long-term survival rates.

5 ciated with an improvement in recurrence and long-term survival rates.

6 for low NT rates, mild NT severity, and low long-term survival rates.

7 ponse to cytotoxic therapy can contribute to long-term survival rates.

8 transplant recipients is associated with low long-term survival rates.

9 re healthy and fertile, and displayed normal long-term survival rates.

10 s alone are not sufficient to achieve better long-term survival rates.

11 Surgery, however, may result in improved long-term survival rates.

12 Early-stage diagnosis is important for long-term survival rates.

13 ent with advanced disease, resulting in poor long-term survival rates.

14 In Western populations, long-term survival rates after curative resection of gas

15 ndomized clinical trials have suggested that long-term survival rates after percutaneous coronary int

16 We sought to determine the long-term survival rates and defect-related morbidity of

17 e among children with rhabdomyosarcoma, with long-term survival rates approaching 70%.

18 Complete remission and long-term survival rates are low for older adults treate

19 , perioperative morbidity and mortality, and long-term survival rates as patients undergoing initial

20 Long-term survival rates at 1, 5, and 8 years were highe

21 We aimed to clarify octogenarian long-term survival rates by stratifying revascularizatio

22 ve management is associated with an improved long-term survival rate, decreased cardiac mortality, an

23 The low long-term survival rate emphasizes the priority of clini

24 The long-term survival rate for patients whose HCC was detec

25 Long-term survival rates for older patients with newly d

26 ters for adenocarcinoma of the pancreas, and long-term survival rates for other periampullary tumors

27 ng a combination of platinum and paclitaxel, long-term survival rates for patients with advanced epit

28 Although short- and long-term survival rates have improved significantly, on

29 However, the long-term survival rates have remained very low.

30 and medical management have greatly improved long-term survival rates in patients with congenital hea

31 leads to sustained disease control and high long-term survival rates in patients with early-stage LP

32 Despite this, the overall long-term survival rate is greater than 90%, which sugge

33 therapies have limited effectiveness and the long-term survival rate is low.

34 st curable pediatric and adult cancers, with long-term survival rates now exceeding 90% after treatme

35 ociated collagen signature-3 (TACS-3) to the long-term survival rate of human patients.

36 4-1BB activation) significantly improves the long-term survival rate of large tumor-bearing mice.

37 ith 4-1BB costimulation greatly improved the long-term survival rate of mice bearing large tumors and

38 Pancreatic cancer is associated with a poor long-term survival rate of only 10% to 15% after resecti

39 is for patients with localized osteosarcoma; long-term survival rates of less than 20% improved to 65

40 of a dialysis-like treatment and may improve long-term survival rates of ovarian cancer patients.

41 To compare long-term survival rates of patients with first, primary

42 Enhanced long-term survival rates of young women with cancer and

43 r, there has been no significant increase in long-term survival rates over the past 30 years.

44 plus cisplatin is feasible with a reasonable long-term survival rate, particularly for patients who c

45 tes are not necessarily associated with high long-term survival rates, suggesting that regimens may n

46 episode of mild AKI have significantly lower long-term survival rates than critically ill patients wi

47 nificantly lower recurrence rates and higher long-term survival rates than other existing treatment m

48 an ablative dose of RT for large IHCCs, with long-term survival rates that compare favorably with res

49 The long-term survival rate was similar between the two rese

50 outcome, resectability rate, pathology, and long-term survival rate were compared with 690 concurren

51 Overall local response rates and long-term survival rates were assessed.

52 Long-term survival rates were better, and fibrosis score

53 In contrast, long-term survival rates were higher for patients with e

54 crowns and fixed dental prostheses have high long-term survival rates when inserted with conventional